Form 4 for VNRX VOLITIONRX LTD
Accepted 2025-01-17 00:00:00 ET · period of report 2025-01-15 · accession 0001477932-25-000326 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 2025-01-15 | VNRX | Innes Guy Archibald | Dir | A - Grant | $0.00 | +50.0K | 667.1K | +8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | A | A | 50,000 | $0.00 | 667,085 | D | — | — | (F1) The reporting person received 50,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, vesting in three installments of 16,667 units, 16,667 units, and 16,666 units on each of January 15, 2026, January 15, 2027 and January 15, 2028, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |